## Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia To the editor: We report on a pediatric and an adult patient suffering from Crohn's disease (CD), treated with mercaptopurine (6-MP) and anti-TNF-a therapy, who respectively subsequently developed MDS with monos
IgA multiple myeloma presenting as an acquired bullous disorder
✍ Scribed by Deanna A Wong; Michelle J Hunt; Karen Stapleton
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 209 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0004-8380
No coin nor oath required. For personal study only.
✦ Synopsis
A 63‐year‐old man presented with an intensely pruritic vesiculo‐bullous eruption on the limbs and was subsequently found to have an IgAκ multiple myeloma. The eruption clinically and histologically was suggestive of linear IgA disease (LAD), dermatitis herpetiformis (DH), epidermolysis bullosa acquisita (EBA), or bullous lupus erythematosus (LE), with the skin biopsy revealing subepidermal bullae and dermal papillary microabscesses. However, direct immunofluorescence showed a unique pattern of diffuse dermal IgA staining. Although chemotherapy produced a dramatic resolution of the lesions, which paralleled the fall in serum IgA paraprotein level, the myeloma later became progressive and the resulting paraprotein increase was accompanied by recurrence of the eruption. We propose that this patient’s rash was the presenting manifestation of his multiple myeloma, and was a consequence of transudation of IgA paraprotein into the dermis.
📜 SIMILAR VOLUMES